Bioventus Inc
NASDAQ:BVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Golden Solar New Energy Technology Holdings Ltd
HKEX:1121
|
CN |
Bioventus Inc
Intangible Assets
Bioventus Inc
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bioventus Inc
NASDAQ:BVS
|
Intangible Assets
$368.4m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Figs Inc
NYSE:FIGS
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Intangible Assets
$633.6m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
26%
|
CAGR 10-Years
39%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Intangible Assets
$93.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
18%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Intangible Assets
$722.8m
|
CAGR 3-Years
32%
|
CAGR 5-Years
14%
|
CAGR 10-Years
38%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Intangible Assets
$537.7m
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
|
Bioventus Inc
Glance View
Bioventus, Inc. global medical technology company which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. The company is headquartered in Durham, North Carolina and currently employs 1,200 full-time employees. The company went IPO on 2021-02-11. The firm is focused on developing and commercializing clinically and minimally invasive treatments that engage and enhance the body’s natural healing process. The Company’s portfolio of products includes OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. The OA joint pain treatment and joint preservation is focused on orthopedics. Its bone graft substitutes (BGSs) offers portfolio of products including human tissue allografts and synthetics. Its BGS products can be used in conjunction with any orthopedic fixation and spinal fusion implant. They are designed to improve bone fusion rates following spinal fusion and other orthopedic surgeries and reduce the need for using the patient’s own bone.
See Also
What is Bioventus Inc's Intangible Assets?
Intangible Assets
368.4m
USD
Based on the financial report for Dec 31, 2025, Bioventus Inc's Intangible Assets amounts to 368.4m USD.
What is Bioventus Inc's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
14%
Over the last year, the Intangible Assets growth was -9%. The average annual Intangible Assets growth rates for Bioventus Inc have been -29% over the past three years , 14% over the past five years .
